Joint Formulary & PAD

Sucralfate - Gastro protection

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral suspension
Associated Icons :
Restrictions / Comments :
 

Status 2

Red
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

Unlicensed product.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Sucralfate
Indication :
Gastro protection
Group Name :
Keywords :
gastric ulcers, stomach ulceration, mucosal protection
Brand Names Include :
Antepsin, Carafate, Sulcrate
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Sucralfate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Gastro protection.

Committee Recommendations (1)

The manufacture of sucralfate tablets and suspension have been discontinued in the UK.

The PCN and gastroenterology colleagues agree that the prescribing and supply of sucralfate should remain with the hospital / specilaist.
As such, sucralfate preparations are RED on the tarffic light system.

See policy statement below for details